DXS International (AQSE:DXSP) Operating Income: £-0.13 Mil (TTM As of Apr. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is DXS International Operating Income?

DXS International AQSE:DXSP Operating Income is £-0.13 Mil as of Apr. 2025. The stock has 2 warning signs investors should review.

DXS International's Operating Income for the six months ended in Apr. 2025 was £-0.13 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Apr. 2025 was £-0.13 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. DXS International's Operating Income for the six months ended in Apr. 2025 was £-0.13 Mil. DXS International's Revenue for the six months ended in Apr. 2025 was £3.47 Mil. Therefore, DXS International's Operating Margin % for the quarter that ended in Apr. 2025 was -3.72%.

DXS International's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. DXS International's annualized ROC % for the quarter that ended in Apr. 2025 was -3.29%. DXS International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2025 was -37.03%.


DXS International  (AQSE:DXSP) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

DXS International's annualized ROC % for the quarter that ended in Apr. 2025 is calculated as:

ROC % (Q: Apr. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Apr. 2024 ) + Invested Capital (Q: Apr. 2025 ))/ count )
=-0.129 * ( 1 - 45.71% )/( (2.316 + 1.937)/ 2 )
=-0.0700341/2.1265
=-3.29 %

where

Note: The Operating Income data used here is one times the annual (Apr. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

DXS International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Apr. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Apr. 2024  Q: Apr. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.127/( ( (0.001 + max(0.685, 0)) + (0 + max(-0.237, 0)) )/ 2 )
=-0.127/( ( 0.686 + 0 )/ 2 )
=-0.127/0.343
=-37.03 %

where Working Capital is:

Working Capital(Q: Apr. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.811 + 0 + 0.256) - (0.255 + 0 + 0.127)
=0.685

Working Capital(Q: Apr. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.321 + 0 + 0.085) - (0.427 + 0 + 0.216)
=-0.237

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Apr. 2025) EBIT data.

3. Operating Income is also linked to Operating Margin %:

DXS International's Operating Margin % for the quarter that ended in Apr. 2025 is calculated as:

Operating Margin %=Operating Income (Q: Apr. 2025 )/Revenue (Q: Apr. 2025 )
=-0.129/3.47
=-3.72 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


DXS International Operating Income Related Terms


DXS International Operating Income Historical Data

* Premium members only.

The historical data trend for DXS International's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DXS International Operating Income Chart

DXS International Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 -0.06 -0.04 -0.50 -0.13

DXS International Semi-Annual Data
Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.30 -0.06 -0.04 -0.50 -0.13

DXS International Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Operating Income for the trailing twelve months (TTM) ended in Apr. 2025 was £-0.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of £-0.13 Mil mean?
DXS International (AQSE:DXSP) has a Operating Income of £-0.13 Mil as of Apr. 2025. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on DXS International and its competitors.
Is DXS International's Operating Income too high?
DXS International's current Operating Income is £-0.13 Mil.
How does DXS International's Operating Income compare to VEEV and BTSG?
DXS International's Operating Income of £-0.13 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Healthcare Providers & Services company?
A good Operating Income depends on the Healthcare Providers & Services industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on DXS International and its competitors. DXS International's current Operating Income is £-0.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DXS International stock overvalued right now?
Based on GuruFocus' analysis, DXS International (AQSE:DXSP) is currently considered Modestly Undervalued. The stock's GF Value™ is £0.02, compared to a current price of £0.02 — trading 20% below its estimated fair value. The current Operating Income is £-0.13 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For DXS International (AQSE:DXSP), the current Operating Income is £-0.13 Mil as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DXS International Business Description

Address 119 Saint Mary’s Road, Market Harborough, London, Leicestershire, GBR, LE16 7DT
DXS International PLC is engaged in the development and distribution of clinical decision support systems for General Practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its commercial activities include licensing DXS products to various ICBs, offering e-detailing opportunities to the pharmaceutical industry and the UK primary care sector, and licensing its technology to healthcare publishers. The company's products include BestPathway and Point-of-Care ExpertCare.